Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.

Journal of thrombosis and thrombolysis - 1 Jun 2008

Kovac Mirjana, Mikovic Danijela, Antonijevic Nebojsa, Rakicevic Ljiljana, Djordjevic Valentina, Radojkovic Dragica, Elezovic Ivo

Abstract excerpt

The absolute rate of recurrence of venous thromboembolism (VTE) is approximately 5% per year. There is a lower rate of recurrence in provoked VTE, and higher in idiopathic one. So far, there is no consensus whether hereditary thrombophilia should be considered as a persistent risk factor, and whether it requires long-term anticoagulant therapy. The aim of our study was to estimate the risk of recurrent VTE in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Incidence

Share to Recurrence

Share to Risk Assessment

Share to Thrombophilia

Share to Venous Thromboembolism

Share to Yugoslavia

Source

Identifiers

PMID: 17549437
DOI: 10.1007/s11239-007-0059-z

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.PMID 17549437Read ↗

Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.Semantic proximity Read ↗

Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism.Semantic proximity Read ↗

The Association of Prothrombin Gene G20210A Mutation with Recurrent Venous Thromboembolism: Evidence from a Meta-Analysis.Semantic proximity Read ↗

Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Semantic proximity Read ↗

The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation.Semantic proximity Read ↗

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.Semantic proximity Read ↗

Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.Semantic proximity Read ↗

Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study.Semantic proximity Read ↗

Recurrent Thromboembolism due to Factor V Leiden Mutation: A Case ReportSemantic proximity Read ↗

The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.Semantic proximity Read ↗

The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationSemantic proximity Read ↗

The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.